Medtronic (NYSE:MDT) announced results from two studies evaluating the utility of atherectomy for peripheral endovascular interventions.

Medtronic announced results from two studies evaluating the utility of atherectomy for peripheral endovascular interventions.

The growth of the stent graft balloon catheter market is primarily driven by the increasing prevalence of cardiovascular ...

Rockville, MD, Oct. 28, 2024 (GLOBE NEWSWIRE) -- The global peripheral stent implant market is set to be valued at US$ 4.11 billion in 2024 and is projected to expand at 6.6% CAGR from 2024 to 2034.

Report Ocean has published a new report on the Peripheral Vascular Devices Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The report ...

Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation ...

The global stent delivery systems market is poised for significant growth, with projections indicating an increase from USD 11.03 billion in 2022 to an estimated USD 21.7 billion by 2032. This ...

and will compare it to an historical control group of patients that have received drug-eluting stents through Medtronic’s prior clinical studies of its Resolute Onyx implant. Participants in ...

Boston's coronary stent ... Medtronic, and Abbott hold more than 90% of the global CRM market, by our estimates. The presence of these top-tier competitors has remained unscathed by the peripheral ...

Endospan has completed enrollment in the primary arm of a clinical trial evaluating its stent graft for the treatment of ...